Filter
1312
Text search:
drug
regimens
Featured
167
327
Language
Document type
766
229
173
55
32
23
19
7
3
3
1
Countries / Regions
74
47
36
36
33
30
26
25
25
24
20
20
18
18
14
13
12
12
12
12
10
10
9
9
9
8
8
8
8
7
7
7
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
462
194
56
49
30
15
13
Toolboxes
300
224
62
49
40
32
30
24
22
18
16
11
11
9
6
4
4
4
2
2
2
2
2
1
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-
...
Policy and Manual
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Division of Global Migration and Quarantine
April 16, 2012
NSP Review
Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013
A publication of the Treatment Action Campaign and SECTION27
GeneXpert: An imperfect rollout
TB in South African prisons: Where to now?
Decentralising DR-TB care: How far alon
...
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Towards ending tuberculosis and multidrug-resistant tuberculosis.
17–24 November 2015
4–15 February 2013
South Eastern European Journal of Public Health, EEJPH 2016, posted: 11 January 2016. DOI 10.4119/UNIBI/SEEJPH-2016-85
14–22 April 2015
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care
...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med
...
Paediatrics
Chapter I.2
